» Articles » PMID: 29210864

Geographical Variations in Hypertension Prevalence, Awareness, Treatment and Control in China: Findings from a Nationwide and Provincially Representative Survey

Overview
Journal J Hypertens
Date 2017 Dec 7
PMID 29210864
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Hypertension has been the most important risk factor for disease burden in China. We aimed to conduct the first national spatial analysis of hypertension status, awareness, treatment and control in China.

Methods: Choropleth maps were used to examine the spatial patterning of hypertension, awareness, treatment and control in a nationally and provincially representative sample of 174 389 adults from the 2013 to 2014 China Chronic Disease and Risk Factors Surveillance. Multilevel regressions were used to analyze each outcome across provinces, counties, towns and villages/residential committees and to test the proportion of area-level variances explained by known risk factors.

Results: Hypertension prevalence was highest in the north (e.g. Liaoning = 37.7%) and lowest in the south (e.g. Hainan = 17.9%). Among participants found to have hypertension, awareness was generally low, especially in the south (e.g. Guizhou = 18.0%). Receipt of treatment among those who were aware of their hypertension status was above 70% in all provinces except for Tibet (37.7%) and Guizhou (54.5%). Control of hypertension among those receiving treatment (SBP < 140 and DBP < 90 mmHg) was generally low, especially in northeastern and southwestern provinces. Adjustment for demographic, socioeconomic and behavioral factors, weight status, healthcare use and urbanization of residence accounted for 57.7% of variation between provinces in hypertension status, 48.5% in awareness, 47.6% in treatment and 18.0% in control.

Conclusion: Hypertension is spatially patterned in China and there is an unmet need at each step from diagnosis to receiving treatment and achieving controlled hypertension. Geographically targeted strategies are required to enhance hypertension prevention and management in China.

Citing Articles

Geographical variation in dementia prevalence across China: a geospatial analysis.

Liu Y, Gao X, Zhang Y, Zeng M, Liu Y, Wu Y Lancet Reg Health West Pac. 2024; 47:101117.

PMID: 38974661 PMC: 11225804. DOI: 10.1016/j.lanwpc.2024.101117.


Assessing the evolution of hypertension management in Gansu, China: A comparative study of prevalence, awareness, treatment, and control in 2012 and 2022.

Liang W, Zhang X, Wang Q, Yu H, Yu J J Clin Hypertens (Greenwich). 2024; 26(6):674-686.

PMID: 38577938 PMC: 11180686. DOI: 10.1111/jch.14809.


Recent studies on hypertension prevalence and control in India 2023.

Gupta R, Gaur K, Ahuja S, Anjana R Hypertens Res. 2024; 47(6):1445-1456.

PMID: 38379011 DOI: 10.1038/s41440-024-01585-y.


Using routinely collected data to determine care cascades of hypertension and type-2 diabetes management in China: a cross-sectional study.

Xiong S, Jiang W, Wang Y, Hu C, Yang J, Bao M Lancet Reg Health West Pac. 2024; 45:101019.

PMID: 38371948 PMC: 10869296. DOI: 10.1016/j.lanwpc.2024.101019.


The Prevalence of Hypertension and Obesity in Iranian Professional Drivers.

Nikpajouh A, Noohi F, Malakpour M, Tajik M, Mahmoudzadeh A, Moghadam P Iran J Public Health. 2023; 52(10):2169-2178.

PMID: 37899925 PMC: 10612542. DOI: 10.18502/ijph.v52i10.13855.